Briefing

Pharmacy Briefing

03 May 2022 - By Brian N. Anderson, Rebekah D. Bayram, Marc Guieb

We detail the latest on pharmacy news, trends, and insights, including items on the company and state levels, FDA approvals and launches, and clinical trials.

12 April 2022 - By Brian N. Anderson, Rebekah D. Bayram, Marc Guieb

We detail the latest on pharmacy news, trends, and insights, including items on the company and state levels, FDA approvals and launches, and clinical trials.

10 February 2022 - By Brian N. Anderson, Rebekah D. Bayram, Marc Guieb

We detail the latest on pharmacy news, trends, and insights.

02 December 2021 - By Brian N. Anderson, Rebekah D. Bayram, Marc Guieb

We detail the latest on pharmacy news, trends, and insights, including FDA approvals of changes to COVID-19 vaccine administration

29 October 2021 - By Brian N. Anderson, Rebekah D. Bayram, Marc Guieb

Highlights include CVS Health and OptumRx announcement, White House action plan, and FDA authorizes COVID-19 booster doses.

29 September 2021 - By Marc Guieb

We cover the industry highlights, including news items, FDA approvals and launches, and clinical trials.

31 August 2021 - By Marc Guieb

Pharmacy Briefing is a monthly summary of select U.S. Food and Drug Administration (FDA) approvals and launches, treatment guidelines and research updates, and other newsworthy events that have the potential to impact commercial drug utilization or costs.

We’re here to help

Ask the tough questions. We’re ready for them.